NICE backs drug to reduce stroke risk for AF patients
The National Institute for Clinical Excellence is now recommending the use of apixaban for some patients with irregular heartbeats to help prevent them experiencing stroke or systemic embolism.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units